Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

NCT04356729

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Neoplasms, +13 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

NCT01783535

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions: Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations: CARTI Cancer Center Little Rock, Arkansas, United States

Salinas Valley Memorial Healthcare System Salinas, California, United States

AdventHealth Orlando Orlando, Florida, United States

Memorial Health System Pembroke Pines, Florida, United States

View Trial Details

Active, Not Recruiting

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

NCT02177578

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Sibley Memorial Hospital Washington D.C., District of Columbia, United States

The SKCCC at Johns Hopkins Baltimore, Maryland, United States

Suburban Hospital Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

NCT03277638

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

NCT05120284

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Active, Not Recruiting

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

NCT06157541

Conditions: Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +9 more
Locations: Newro Foundation Bowen Hills, Queensland, Australia

Royal Brisbane and Women's Hospital Herston, Queensland, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Austin Hospital Heidelberg, Victoria, Australia

View Trial Details

Active, Not Recruiting

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

NCT02142803

Conditions: Adnexal Diseases, Adult Glioblastoma, Astrocytoma, +47 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Charlestown, Massachusetts, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

NCT00539591

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Rady Children's Hospital San Diego, California, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

The Children's Cancer Hospital at UT M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

NCT03175432

Conditions: BRAF V600 Wild Type, Brain Diseases, Brain Neoplasms, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions